Highly active antiretroviral therapy among drug users in Amsterdam : self-perceived reasons for not receiving therapy

In the Netherlands, highly active antiretroviral therapy (HAART), i.e. triple combination treatment including a protease inhibitor (PI), became widely available in July 1996. However, studies among drug users (DUs) have reported a delay in the start of combination therapy or low treatment percentage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 1999-07, Vol.13 (10), p.1280-1281
Hauptverfasser: VAN DER WERF, M. J, SCHINKEL, J, VAN SANTEN, G, VERGOUWE, I, WIX, R. A, VAN AMEIJDEN, E. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1281
container_issue 10
container_start_page 1280
container_title AIDS (London)
container_volume 13
creator VAN DER WERF, M. J
SCHINKEL, J
VAN SANTEN, G
VERGOUWE, I
WIX, R. A
VAN AMEIJDEN, E. J
description In the Netherlands, highly active antiretroviral therapy (HAART), i.e. triple combination treatment including a protease inhibitor (PI), became widely available in July 1996. However, studies among drug users (DUs) have reported a delay in the start of combination therapy or low treatment percentages compared with other risk groups, which might be caused by several risk group-related reasons, including poor knowledge, low healthcare-seeking behaviour and access, and anticipated problems with compliance due to drug use, lifestyle, psychopathology, imprisonment, and housing problems.
doi_str_mv 10.1097/00002030-199907090-00022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17424354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17424354</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-905efefb5876c2639066bd5b9c7adb59920c4709f16e29a5ab632bcb8db7aa1e3</originalsourceid><addsrcrecordid>eNpNkE1vGyEQhlGVqnbc_oWKQ5XbJnwssPRmRWkTyVIv7Xk1sLM21X64sGvJ_z44dpNwGcE886J5CKGc3XJmzR3LRzDJCm6tZYZZVpxexAey5KWRhVKGX5ElE9oWVhq2INcp_c2IYlX1iSw4K7lW0izJ_Bi2u-5IwU_hgBSGKUSc4ngIETo67TDCPnf7cdjSJs5bOieMiYaBrvs0YWygp99pwq4t9hg95pCGRoQ0Dom2Y6TDOOX7qRFyxCXwM_nYQpfwy6WuyJ8fD7_vH4vNr59P9-tN4UvBp8IyhS22TlVGe6GlZVq7RjnrDTROWSuYL_P2LdcoLChwWgrnXdU4A8BRrsjNOXcfx38zpqnuQ_LYdTDgOKeam1KUUpUZrM6gj2NKEdt6H0MP8VhzVp-U1_-V16_K6xflefTr5Y_Z9di8Gzw7zsC3CwDJQ9dGGHxIb1ylc1wpnwGmjYtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17424354</pqid></control><display><type>article</type><title>Highly active antiretroviral therapy among drug users in Amsterdam : self-perceived reasons for not receiving therapy</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>VAN DER WERF, M. J ; SCHINKEL, J ; VAN SANTEN, G ; VERGOUWE, I ; WIX, R. A ; VAN AMEIJDEN, E. J</creator><creatorcontrib>VAN DER WERF, M. J ; SCHINKEL, J ; VAN SANTEN, G ; VERGOUWE, I ; WIX, R. A ; VAN AMEIJDEN, E. J</creatorcontrib><description>In the Netherlands, highly active antiretroviral therapy (HAART), i.e. triple combination treatment including a protease inhibitor (PI), became widely available in July 1996. However, studies among drug users (DUs) have reported a delay in the start of combination therapy or low treatment percentages compared with other risk groups, which might be caused by several risk group-related reasons, including poor knowledge, low healthcare-seeking behaviour and access, and anticipated problems with compliance due to drug use, lifestyle, psychopathology, imprisonment, and housing problems.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/00002030-199907090-00022</identifier><identifier>PMID: 10416537</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Anti-HIV Agents - therapeutic use ; Biological and medical sciences ; Cohort Studies ; Drug Therapy, Combination ; Female ; Highly active antiretroviral therapy ; HIV Infections - complications ; HIV Infections - drug therapy ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Infectious diseases ; Male ; Medical sciences ; Netherlands ; Netherlands, Amsterdam ; Physician-Patient Relations ; Substance Abuse, Intravenous - complications ; Treatment Refusal ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>AIDS (London), 1999-07, Vol.13 (10), p.1280-1281</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-905efefb5876c2639066bd5b9c7adb59920c4709f16e29a5ab632bcb8db7aa1e3</citedby><cites>FETCH-LOGICAL-c421t-905efefb5876c2639066bd5b9c7adb59920c4709f16e29a5ab632bcb8db7aa1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1860704$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10416537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VAN DER WERF, M. J</creatorcontrib><creatorcontrib>SCHINKEL, J</creatorcontrib><creatorcontrib>VAN SANTEN, G</creatorcontrib><creatorcontrib>VERGOUWE, I</creatorcontrib><creatorcontrib>WIX, R. A</creatorcontrib><creatorcontrib>VAN AMEIJDEN, E. J</creatorcontrib><title>Highly active antiretroviral therapy among drug users in Amsterdam : self-perceived reasons for not receiving therapy</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>In the Netherlands, highly active antiretroviral therapy (HAART), i.e. triple combination treatment including a protease inhibitor (PI), became widely available in July 1996. However, studies among drug users (DUs) have reported a delay in the start of combination therapy or low treatment percentages compared with other risk groups, which might be caused by several risk group-related reasons, including poor knowledge, low healthcare-seeking behaviour and access, and anticipated problems with compliance due to drug use, lifestyle, psychopathology, imprisonment, and housing problems.</description><subject>Adult</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Netherlands</subject><subject>Netherlands, Amsterdam</subject><subject>Physician-Patient Relations</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Treatment Refusal</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1vGyEQhlGVqnbc_oWKQ5XbJnwssPRmRWkTyVIv7Xk1sLM21X64sGvJ_z44dpNwGcE886J5CKGc3XJmzR3LRzDJCm6tZYZZVpxexAey5KWRhVKGX5ElE9oWVhq2INcp_c2IYlX1iSw4K7lW0izJ_Bi2u-5IwU_hgBSGKUSc4ngIETo67TDCPnf7cdjSJs5bOieMiYaBrvs0YWygp99pwq4t9hg95pCGRoQ0Dom2Y6TDOOX7qRFyxCXwM_nYQpfwy6WuyJ8fD7_vH4vNr59P9-tN4UvBp8IyhS22TlVGe6GlZVq7RjnrDTROWSuYL_P2LdcoLChwWgrnXdU4A8BRrsjNOXcfx38zpqnuQ_LYdTDgOKeam1KUUpUZrM6gj2NKEdt6H0MP8VhzVp-U1_-V16_K6xflefTr5Y_Z9di8Gzw7zsC3CwDJQ9dGGHxIb1ylc1wpnwGmjYtQ</recordid><startdate>19990709</startdate><enddate>19990709</enddate><creator>VAN DER WERF, M. J</creator><creator>SCHINKEL, J</creator><creator>VAN SANTEN, G</creator><creator>VERGOUWE, I</creator><creator>WIX, R. A</creator><creator>VAN AMEIJDEN, E. J</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19990709</creationdate><title>Highly active antiretroviral therapy among drug users in Amsterdam : self-perceived reasons for not receiving therapy</title><author>VAN DER WERF, M. J ; SCHINKEL, J ; VAN SANTEN, G ; VERGOUWE, I ; WIX, R. A ; VAN AMEIJDEN, E. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-905efefb5876c2639066bd5b9c7adb59920c4709f16e29a5ab632bcb8db7aa1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Netherlands</topic><topic>Netherlands, Amsterdam</topic><topic>Physician-Patient Relations</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Treatment Refusal</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAN DER WERF, M. J</creatorcontrib><creatorcontrib>SCHINKEL, J</creatorcontrib><creatorcontrib>VAN SANTEN, G</creatorcontrib><creatorcontrib>VERGOUWE, I</creatorcontrib><creatorcontrib>WIX, R. A</creatorcontrib><creatorcontrib>VAN AMEIJDEN, E. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAN DER WERF, M. J</au><au>SCHINKEL, J</au><au>VAN SANTEN, G</au><au>VERGOUWE, I</au><au>WIX, R. A</au><au>VAN AMEIJDEN, E. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Highly active antiretroviral therapy among drug users in Amsterdam : self-perceived reasons for not receiving therapy</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>1999-07-09</date><risdate>1999</risdate><volume>13</volume><issue>10</issue><spage>1280</spage><epage>1281</epage><pages>1280-1281</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>In the Netherlands, highly active antiretroviral therapy (HAART), i.e. triple combination treatment including a protease inhibitor (PI), became widely available in July 1996. However, studies among drug users (DUs) have reported a delay in the start of combination therapy or low treatment percentages compared with other risk groups, which might be caused by several risk group-related reasons, including poor knowledge, low healthcare-seeking behaviour and access, and anticipated problems with compliance due to drug use, lifestyle, psychopathology, imprisonment, and housing problems.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>10416537</pmid><doi>10.1097/00002030-199907090-00022</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-9370
ispartof AIDS (London), 1999-07, Vol.13 (10), p.1280-1281
issn 0269-9370
1473-5571
language eng
recordid cdi_proquest_miscellaneous_17424354
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Adult
Anti-HIV Agents - therapeutic use
Biological and medical sciences
Cohort Studies
Drug Therapy, Combination
Female
Highly active antiretroviral therapy
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus 1
Human viral diseases
Humans
Infectious diseases
Male
Medical sciences
Netherlands
Netherlands, Amsterdam
Physician-Patient Relations
Substance Abuse, Intravenous - complications
Treatment Refusal
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
title Highly active antiretroviral therapy among drug users in Amsterdam : self-perceived reasons for not receiving therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A14%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Highly%20active%20antiretroviral%20therapy%20among%20drug%20users%20in%20Amsterdam%20:%20self-perceived%20reasons%20for%20not%20receiving%20therapy&rft.jtitle=AIDS%20(London)&rft.au=VAN%20DER%20WERF,%20M.%20J&rft.date=1999-07-09&rft.volume=13&rft.issue=10&rft.spage=1280&rft.epage=1281&rft.pages=1280-1281&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/00002030-199907090-00022&rft_dat=%3Cproquest_cross%3E17424354%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17424354&rft_id=info:pmid/10416537&rfr_iscdi=true